IL22 and psoriasis: Despite the growing number of biological therapies that are entering the clinical arena, many more biological remain on the horizon, including the targeting of IL-21[45] or IL-22.[10] With time, long-term side effects and efficacies will become clearer and help determine which ones are the most suitable for long-term care of psoriasis.